744 results on '"Fiorentino, Michelangelo"'
Search Results
2. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation
3. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT
4. Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features
5. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis
6. TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
7. Site-specific concordance of targeted and systematic biopsy cores at the index lesion on multiparametric magnetic resonance: can we spare the double-tap?
8. “Paradoxical” p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules
9. TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis
10. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma
11. Microbiota and prostate cancer
12. PRAME Expression in Mucosal Melanoma of the Head and Neck Region
13. Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care
14. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors
15. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones
16. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer
17. The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
18. Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience
19. Immunophenotypical assessment supports that post‐chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and 'somatic‐type' adenocarcinoma.
20. The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice
21. [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
22. Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning
23. PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors
24. β‐Catenin alterations in testicular Leydig cell tumour: a immunohistochemical and molecular analysis.
25. Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study
26. Infiltration of M2 Macrophages and Regulatory T Cells Plays a Role in Recurrence of Renal Cell Carcinoma
27. Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma
28. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets
29. Pd-ligand 1 is expressed in inflammatory cells but not in neoplastic cells in hepatocellular carcinoma: An immunohistochemical study
30. Secondary bladder amyloidosis due to Crohn’s disease: a case report and literature review
31. Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer
32. New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes
33. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data
34. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
35. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes
36. The Metabolic Landscape of Prostate Cancer
37. Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer
38. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss
39. Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study
40. Molecular Imaging and Precision Medicine in Prostate Cancer
41. PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma
42. The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome
43. Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
44. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer
45. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression
46. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade
47. A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor
48. Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort.
49. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type.
50. Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health Professionals.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.